Skip to main content

Table 2 Significantly altered miRNAs for samples

From: MicroRNA modulation in complex regional pain syndrome

Variable

p value

Variable

p value

hsa-miR-25#

9.29E-09

hsa-miR-20a#

0.00454

hsa-let-7c

4.33E-08

hsa-miR-16-1#

0.005137

hsa-let-7b

7.35E-08

hsa-miR-106b

0.00535

hsa-miR-320

6.06E-07

hsa-miR-532-3p

0.00535

hsa-miR-181a-2#

6.64E-05

hsa-miR-142-5p

0.005419

hsa-miR-190b

0.0006

hsa-miR-342-5p

0.005419

hsa-miR-221

0.000721

has-miR-155

0.00595

hsa-miR-629

0.002053

hsa-miR-130b

0.007069

hsa-miR-93

0.002053

hsa-miR-185

0.007069

hsa-miR-590-5p

0.002053

hsa-miR-181c

0.007069

hsa-miR-29b-2#

0.00306

hsa-miR-20b

0.007154

hsa-miR-181a

0.003087

hsa-let-7a

0.009386

hsa-miR-144#

0.003087

hsa-miR-422a

0.009471

hsa-miR-196b

0.003908

hsa-miR-340

0.009501

hsa-miR-132

0.004131

hsa-miR-324-3p

0.009501

hsa-miR-652

0.004131

hsa-miR-598

0.009975

hsa-let-7g

0.004305

hsa-let-7d

0.009975

  1. Significantly altered miRNAs for samples that clustered in Group 3, based on the miRNA profiling. The statistical significance was calculated using 2-tailed t-tests on the miRNA expression levels in patients that were in Group 3 versus other CRPS patients and control samples.